Article Text

Download PDFPDF
Original research article
Cardiovascular risk in 159 934 frequent blood donors while addressing the healthy donor effect

Footnotes

  • Contributors KP is the guarantor for this study. All authors contributed to the study design and data interpretation. FA, ALMV, MdH and WLAMdK wrote the proposal. KP collected the data, conducted the statistical analysis and wrote the first draft of the paper. FA, ALMV and MdH assisted in the methodology and statistical procedures. All authors contributed to further drafts of the paper and approved the final version. KP, FA and MdH had full access to all of the data, and ALMV and WLAMdK had access to statistical reports and tables of the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.

  • Funding This study was funded by Sanquin Blood Supply, Grant Product and Process Development Cellular Products-09-024.

  • Competing interests None declared.

  • Ethics approval The accredited Medical Research Ethics Committee Region Arnhem-Nijmegen approved this study’s protocol under registration number 2010/103.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Statistical code and output is available (in Dutch) from the corresponding author at Femke.Atsma@radboudumc.nl. Results are based on calculations by Sanquin Research using non-public microdata from Statistics Netherlands. Under certain conditions, these microdata are accessible for statistical and scientific research. For further information: microdata@cbs.nl.

  • Correction notice Since this paper was first published online, the corresponding author address has been updated.

  • Patient consent for publication Not required.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors KP is the guarantor for this study. All authors contributed to the study design and data interpretation. FA, ALMV, MdH and WLAMdK wrote the proposal. KP collected the data, conducted the statistical analysis and wrote the first draft of the paper. FA, ALMV and MdH assisted in the methodology and statistical procedures. All authors contributed to further drafts of the paper and approved the final version. KP, FA and MdH had full access to all of the data, and ALMV and WLAMdK had access to statistical reports and tables of the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.

  • Funding This study was funded by Sanquin Blood Supply, Grant Product and Process Development Cellular Products-09-024.

  • Competing interests None declared.

  • Ethics approval The accredited Medical Research Ethics Committee Region Arnhem-Nijmegen approved this study’s protocol under registration number 2010/103.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Statistical code and output is available (in Dutch) from the corresponding author at Femke.Atsma@radboudumc.nl. Results are based on calculations by Sanquin Research using non-public microdata from Statistics Netherlands. Under certain conditions, these microdata are accessible for statistical and scientific research. For further information: microdata@cbs.nl.

  • Correction notice Since this paper was first published online, the corresponding author address has been updated.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.